| Date | Time | Source | Headline | Symbol | Company |
| 04/30/2024 | 12:53PM | iHub Newswire | FeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia | | |
| 12/10/2018 | 8:31AM | GlobeNewswire Inc. | Edison issues initiation on ADL Bionatur Solutions (BNT) | AMEX:ADL | Amdl, |
| 12/10/2018 | 8:30AM | GlobeNewswire Inc. | Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand | AMEX:ADL | Amdl, |
| 09/18/2009 | 2:32PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ADL | Amdl, |
| 09/18/2009 | 9:30AM | PR Newswire (US) | AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US | AMEX:ADL | |
| 08/20/2009 | 9:49AM | PR Newswire (US) | AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc. | AMEX:ADL | |
| 08/19/2009 | 5:30PM | PR Newswire (US) | AMDL Inc. Announces Second Quarter 2009 Financial Results | AMEX:ADL | |
| 08/19/2009 | 5:23PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ADL | Amdl, |
| 08/14/2009 | 4:10PM | Edgar (US Regulatory) | Notification that Quarterly Report will be submitted late (NT 10-Q) | AMEX:ADL | Amdl, |
| 08/14/2009 | 4:00PM | PR Newswire (US) | AMDL Inc. Files Notification of Late Filing for Form 10-Q | AMEX:ADL | |
| 07/22/2009 | 9:30AM | PR Newswire (US) | AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009 | AMEX:ADL | |
| 07/08/2009 | 10:00AM | PR Newswire (US) | AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test | AMEX:ADL | |
| 07/06/2009 | 6:04AM | Edgar (US Regulatory) | Revised Proxy Soliciting Materials (definitive) (DEFR14A) | AMEX:ADL | Amdl, |
| 07/06/2009 | 6:04AM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | AMEX:ADL | Amdl, |
| 06/25/2009 | 5:30PM | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (PRER14A) | AMEX:ADL | Amdl, |
| 06/23/2009 | 12:08PM | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(4) (424B4) | AMEX:ADL | Amdl, |
| 06/17/2009 | 9:30AM | PR Newswire (US) | AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 | AMEX:ADL | |
| 06/15/2009 | 5:33PM | PR Newswire (US) | AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes | AMEX:ADL | |
| 06/15/2009 | 4:22PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ADL | Amdl, |
| 06/11/2009 | 2:39PM | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | AMEX:ADL | Amdl, |
| 05/15/2009 | 6:10PM | PR Newswire (US) | AMDL, Inc. Announces First Quarter 2009 Financial Results | AMEX:ADL | |
| 05/15/2009 | 4:59PM | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3) | AMEX:ADL | Amdl, |
| 05/15/2009 | 4:52PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ADL | Amdl, |
| 05/13/2009 | 6:00PM | PR Newswire (US) | AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer | AMEX:ADL | |
| 05/08/2009 | 9:30AM | PR Newswire (US) | AMDL Inc.'s JJB Plant Receives Production Approval From Chinese State Food and Drug Administration (SFDA) | AMEX:ADL | |
| 05/07/2009 | 12:30PM | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (D) | AMEX:ADL | Amdl, |
| 05/06/2009 | 3:51PM | PR Newswire (US) | AMDL Inc. Announces First Closing of Private Placement of 12% Series Two Senior Notes | AMEX:ADL | |
| 05/06/2009 | 3:07PM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ADL | Amdl, |
| 04/30/2009 | 9:30AM | PR Newswire (US) | AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test | AMEX:ADL | |
| 04/29/2009 | 9:30AM | PR Newswire (US) | Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets | AMEX:ADL | |